GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » QUIA PHARMA AB (OSTO:QUIA) » Definitions » Research & Development

QUIA PHARMA AB (OSTO:QUIA) Research & Development : kr0.03 Mil (TTM As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is QUIA PHARMA AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. QUIA PHARMA AB's Research & Development for the six months ended in Dec. 2024 was kr0.03 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.03 Mil.

QUIA PHARMA AB Research & Development Historical Data

The historical data trend for QUIA PHARMA AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QUIA PHARMA AB Research & Development Chart

QUIA PHARMA AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 2.20 0.13

QUIA PHARMA AB Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1.21 - 0.03

QUIA PHARMA AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QUIA PHARMA AB  (OSTO:QUIA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

QUIA PHARMA AB Research & Development Related Terms

Thank you for viewing the detailed overview of QUIA PHARMA AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

QUIA PHARMA AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » QUIA PHARMA AB (OSTO:QUIA) » Definitions » Research & Development
Comparable Companies
OSTO:NANECH OSTO:STABL XSAT:APTA OSTO:FLUI NGM:DIABIO XSAT:DBP B OSTO:LPGO XSAT:PHAL XSAT:RESP OSTO:2CUREX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
99B0:Germany
Address
Virdings Alle 32 B, Uppsala, SWE, 754 50
Website
https://www.quiapeg.com
QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.

QUIA PHARMA AB Headlines

No Headlines